<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hsu</surname>
    <given-names>J. T. A.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>C. J.</given-names>
   </name>
   <name>
    <surname>Hsieh</surname>
    <given-names>H. P.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y. C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>K. K.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C. P. C.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2004</year>). 
  <article-title>Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV</article-title>. 
  <source>FEBS Lett.</source>
  <volume>574</volume>, 
  <fpage>116</fpage>â€“
  <lpage>120</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.febslet.2004.08.015</pub-id>
  <?supplied-pmid 15358550?>
  <pub-id pub-id-type="pmid">15358550</pub-id>
 </mixed-citation>
</ref>
